Andrew Arno - 11 Apr 2024 Form 4 Insider Report for Oncocyte Corp (OCX)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCX	Common Stock, no par value	Purchase	$99,999	+33,898	+96.4%	$2.95	69,054	11 Apr 2024	Direct	F1
holding	OCX	Common Stock, no par value						7,804	11 Apr 2024	See footnote	F2
holding	OCX	Common Stock, no par value						7,804	11 Apr 2024	See footnote	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Reflects shares of the Issuer's common stock, no par value ("Common Stock"), purchased by the Reporting Person from the Issuer in a private offering.
F2	These shares of Common Stock are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and, in such capacity, has the right to vote and dispose of securities held by JBA, including the shares of Common Stock reported here.
F3	These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and, in such capacity, has the right to vote and dispose of securities held by MJA, including the shares of Common Stock reported here.